← Research status explorer
Peak / Growth axis
GHRP-2
Also known as: Pralmorelin
Current research status
Human Research
Experimental endocrine research
Preclinical
Human Research
Overview
GHRP-2 (pralmorelin) is a ghrelin-receptor agonist studied in human endocrine research, including as a diagnostic stimulation-test agent for growth hormone deficiency in some countries. It has been administered in published human studies but has not gone through a conventional Phase 1–3 program toward broad drug approval.
Last reviewed: September 2026
